-
CRSP Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CRISPR Therapeutics (CRSP)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 309.78 mm | 309.78 mm | 309.78 mm | 309.78 mm | 309.78 mm | 309.78 mm |
Cash burn (monthly) | (no burn) | 7.61 mm | 21.53 mm | 38.88 mm | 16.68 mm | 11.90 mm |
Cash used (since last report) | n/a | 16.07 mm | 45.47 mm | 82.12 mm | 35.22 mm | 25.13 mm |
Cash remaining | n/a | 293.71 mm | 264.31 mm | 227.66 mm | 274.55 mm | 284.65 mm |
Runway (months of cash) | n/a | 38.6 | 12.3 | 5.9 | 16.5 | 23.9 |
13F holders | Current |
---|---|
Total holders | 403 |
Opened positions | 68 |
Closed positions | 82 |
Increased positions | 112 |
Reduced positions | 116 |
13F shares | Current |
---|---|
Total value | 2.32 tn |
Total shares | 79.61 mm |
Total puts | 1.92 mm |
Total calls | 1.55 mm |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
ARK Investment Management | 8.97 mm | $353.18 bn |
Capital International Investors | 8.74 mm | $344.15 bn |
VRTX Vertex Pharmaceuticals | 5.38 mm | $353.37 mm |
T. Rowe Price Investment Management | 3.81 mm | $150.03 mm |
GSK GSK | 3.31 mm | $278.46 mm |
Bayer Global Investments B.V. | 2.95 mm | $154.89 mm |
BlackRock | 2.76 mm | $108.61 bn |
CMTDF Sumitomo Mitsui Trust | 2.75 mm | $108.07 bn |
Nikko Asset Management Americas | 2.75 mm | $108.07 bn |
STT State Street | 2.49 mm | $98.07 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Feb 25 | Greene John | Common Shares | Buy | Acquire P | No | No | 44.8497 | 7,000 | 313.95 k | 7,000 |
19 Feb 25 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 55.205 | 18,360 | 1.01 mm | 171,613 |
19 Feb 25 | Julianne Bruno | Common Shares | Sell | Dispose S | No | No | 52.8 | 333 | 17.58 k | 7,062 |
19 Feb 25 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | No | 52.8 | 6,928 | 365.80 k | 189,973 |
19 Feb 25 | Kasinger James R. | Common Shares | Sell | Dispose S | No | No | 52.8 | 1,947 | 102.80 k | 74,880 |
18 Feb 25 | Julianne Bruno | Common Shares | Option exercise | Acquire M | No | No | 0 | 650 | 0.00 | 7,395 |
18 Feb 25 | Julianne Bruno | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 650 | 0.00 | 650 |
18 Feb 25 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 55.05 | 11,640 | 640.78 k | 196,901 |
18 Feb 25 | Samarth Kulkarni | Common Shares | Option exercise | Acquire M | No | No | 0 | 13,250 | 0.00 | 208,541 |
18 Feb 25 | Samarth Kulkarni | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 13,250 | 0.00 | 13,250 |